Canopy Growth (CGC) Net Cash Flow (2019 - 2026)
Canopy Growth (CGC) posted Net Cash Flow of $187.5 million for Q4 2025, up 1702.38% sequentially from $10.4 million in Q2 2025, and up 548.28% YoY from $28.9 million in Q4 2024.
Canopy Growth (CGC) Net Cash Flow (2019 - 2026) Analysis & Trends
Canopy Growth has reported Net Cash Flow for 7 years, with the latest figure at $187.5 million in Q4 2025.
- Quarterly Net Cash Flow rose 548.28% year-over-year to $187.5 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $198.0 million (up 2111.7% YoY) and the FY2026 annual result came in at $180.3 million, up 498.76% from the prior year.
- Net Cash Flow rose to $187.5 million in Q4 2025 per CGC's latest filing, from $10.4 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $270.7 million in Q1 2021 and troughed at -$476.2 million in Q2 2021.
- A 5-year average of -$8.0 million and a median of $5.4 million in 2024 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2023 and 2025: Net Cash Flow sank 238.26% in 2023, then soared 548.28% in 2025.
- Over 5 years, Net Cash Flow stood at -$152.2 million in 2021, then increased by 5.87% to -$143.3 million in 2022, then jumped by 49.03% to -$73.0 million in 2023, then jumped by 42.7% to -$41.8 million in 2024, then soared by 548.28% to $187.5 million in 2025.
- According to Business Quant data, Net Cash Flow over the past three periods registered $187.5 million, $10.4 million, and -$41.8 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Canopy Growth | 437.04 Mn | 190.03 Mn | 16.08 Mn | -24.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -24.01 Mn |
| Jun 30, 2026 | -24.01 Mn |
| Dec 31, 2025 | 187.55 Mn |
| Dec 31, 2025 | 187.55 Mn |
| Jun 30, 2025 | 10.41 Mn |
| Jun 30, 2025 | 10.41 Mn |
| Dec 31, 2024 | -41.84 Mn |
| Dec 31, 2024 | -41.84 Mn |
| Sep 30, 2024 | 24.09 Mn |
| Sep 30, 2024 | 24.09 Mn |
| Jun 30, 2024 | 7.90 Mn |
| Jun 30, 2024 | 7.90 Mn |
| Mar 31, 2024 | 2.90 Mn |
| Mar 31, 2024 | 2.90 Mn |
| Dec 31, 2023 | -73.02 Mn |
| Dec 31, 2023 | -73.02 Mn |
| Sep 30, 2023 | -250.00 Mn |
| Sep 30, 2023 | -250.00 Mn |
| Jun 30, 2023 | -72.03 Mn |
| Jun 30, 2023 | -72.03 Mn |